Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Official: Iran Producing 4 High-Quality Nano Drugs

Abstract:
Iran is now producing 4 nano drugs, mostly for cancer patients, which enjoy higher quality than the foreign products and at a lower cost, an official announced on Wednesday.

Official: Iran Producing 4 High-Quality Nano Drugs

Tehran, Iran | Posted on July 16th, 2014

"At present, 4 nano drugs are being produced and presented (to the market)," Hossein Shakki, the director of the Iran Nanotechnology Initiative Council (INIC) for Pharmaceutical Industries Commercialization, said.

"The drugs produced in Iran enjoy higher quality (compared with the foreign drugs) at a price one-fourth of their rival foreign products," he added.

Shakki said that the anti-cancer nano drugs are now used in Iran for the treatment of breast and prostate cancers.

Iran has taken wide strides in science and technology, particularly in medical and medicinal fields, in recent years.

Iranian scientists in January 2013 developed the country's first anti-cancer drug using nanotechnology.

"The first anti-cancer medicine was produced in Iran," Head of the Public Relations of the Presidential Office's Technological Cooperation Department Amir Khanian said.

He also said that the Iranian scientists have produced 18 biotech drugs and are carrying out research on another 29 biotech medicines.

The country has already mass-produced Doxorubicin - a non-carcinogenic drug - used in lung and breast cancer cases and made based on nano-liposomes technique. The drug with higher efficiency needs lower times for use and naturally lessens side effects, including vascular and heart complications.

Iran has also produced two other non-carcinogenic medicines Paclitaxel for breast and ovarian cancer and oxaliplatin for colon cancer.

In September 2013, Iranian researchers from Lorestan University succeeded in designing a new type of drug delivery system for anti-cancer drugs by using linear dendritic polymers and iron nanoparticles.

Hybrid nanocomposites were used in this drug delivery system. Carbon nanotubes were also used in the system to make possible the quick passage through cellular walls.

Among the significant characteristic of the research was hybridization of a series of nanomaterials in a system to use all their properties in the elimination of cancerous cells.

Iran is among the very few countries which have developed a remedy for the most fearsome disease in the human community, known as AIDS. In 2007, Iranian scientists found a safe and effective cure for the dreaded virus, AIDS. This medicine made up of herbal and chemical components works to build immunity and enhance the quality of life of both AIDS and HIV-positive patients with no proven side effects.

Five years later, Iran helped Mali control and contain HIV infection across the African nation. A senior official of Iran's Red Crescent Society announced in August 2012 that HIV-infected patients in Mali had shown positive reactions to the Iran-made AIDS curing drug, Imod, in the course of their treatment.

"We have been witnessing highly positive results of Iran-made Imod drug on AIDS patients in Mali during the last two years," Deputy of RCS for Health, Treatment and Rehabilitation Abdolreza Shahrezayee told FNA on August 31, 2012.

He underlined Iran's extended health and treatment services in Mali, and said HIV-positive patients were being cured by Imod in RCS's polyclinic.

####

For more information, please click here

Copyright © Fars News Agency

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Big award enables study of small surfaces: Rice U.'s Matt Jones wins Packard Fellowship to view nanoscale chemical reactions October 15th, 2018

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3 October 15th, 2018

Graphene shows unique potential to exceed bandwidth demands of future telecommunications October 12th, 2018

High-performance self-assembled catalyst for SOFC October 12th, 2018

Nanomedicine

Big award enables study of small surfaces: Rice U.'s Matt Jones wins Packard Fellowship to view nanoscale chemical reactions October 15th, 2018

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3 October 15th, 2018

180 Degree Capital Corp. Announces New Portfolio Holdings Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018

Tracking a Killer: UCSB, UCSD and SBP researchers trace the complex and variable pathways to the deadly condition known as sepsis October 12th, 2018

Announcements

Big award enables study of small surfaces: Rice U.'s Matt Jones wins Packard Fellowship to view nanoscale chemical reactions October 15th, 2018

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3 October 15th, 2018

180 Degree Capital Corp. Announces New Portfolio Holdings Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018

TUBALL single wall carbon nanotubes: No ecotoxicity found, unlike other carbon nanotubes October 12th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project